Showing 1 posts of 1 posts found.
Indian drugmaker Ranbaxy has signed a deal to construct a new $35 million manufacturing facility in Malaysia that will triple …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO